|

TOS-358 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Totus Medicines1

Indications

  • HR+/HER2-negative Breast Cancer1
  • Squamous Cell Carcinoma of Head and Neck1
  • Endometrial Cancer1
  • Bladder Cancer1
  • Breast Cancer1

Los Angeles, California1 trial

A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors

University of Southern California, Norris Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.